We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Details of the new Pharmaceuticals in the Environment (PiE) cross-government group working to reduce the impacts of pharmaceuticals in the environment.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Regulators must use this process guidance note (PGN) to assess applications and write permits for the formulation and finishing of pharmaceutical products
Guidance to help primary care trusts in the assessment and determination of applications to provide NHS pharmaceutical services
Directions given by the Secretary of State for Health under powers conferred by statute.
Register as a manufacturer, importer or distributor of active substances.
The Pharmaceutical Services (Advanced and Enhanced Services)(England) Directions have been consolidated and updated.
A 5-year voluntary scheme on the control of prices agreed between government and the Association of the British Pharmaceutical Industry (ABPI).
Pharmaceutical companies, global health donors and other stakeholders have increasingly recognized the need for a careful analysis.
This Brief presents evidence for health and development benefits from creating stronger linkages between industrial and health agendas
Webinars for pharmaceutical companies, clinical trial sponsors, e-cigarette producers and brokers of medicinal products
Post-implementation report on the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013.
These temporary good manufacturing practice (GMP) flexibilities will be allowed to address the current exceptional circumstances
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).